Cytomegalovirus Infections News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2025 - PR Newswire (press release)



Cytomegalovirus (CMV) Infection - Market Insights, Epidemiology and Market Forecast-2025 
PR Newswire (press release)
Even after such high prevalence, CMV Infection market is flooded with Generic products as the top-selling drugs have gone off-patent. Most recent gone off patent drug was Valcyte, which lost its patent in 2013 and 2015 in the US and Europe ...

and more » 


Merck (MRK) Announces NEJM Publishes Phase 3 Clinical Study of PREVYMIS, Its New CMV Prophylaxis Medicine - StreetInsider.com



MedPage Today
 
Merck (MRK) Announces NEJM Publishes Phase 3 Clinical Study of PREVYMIS, Its New CMV Prophylaxis Medicine 
StreetInsider.com
Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the New England Journal of Medicine has published online the main results from the pivotal Phase 3 clinical study of PREVYMIS? (letermovir), the ...
Antiviral Agent Lowers CMV Risk in Stem Cell Transplant MedPage Today

all 2 news articles » 


Doctors call for action on congenital CMV infection - InDaily



InDaily
 
Doctors call for action on congenital CMV infection 
InDaily
This is by far the most common congenital infection, and causes a larger public health burden than all others including rubella, Zika virus and HIV, says Flinders University Associate Professor Peter Speck, secretary of the Australasian Virology ...

 


Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2017 - PR Newswire (press release)



Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2017 
PR Newswire (press release)
Human Cytomegalovirus Envelope Glycoprotein B (gB) pipeline Target constitutes close to 10 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Human ...

and more » 


Letermovir prophylaxis cuts risk of CMV infection - Medical Xpress



Medical Xpress
 
Letermovir prophylaxis cuts risk of CMV infection 
Medical Xpress
The researchers found that among 495 patients with undetectable CMV DNA at randomization, fewer patients in the letermovir group had clinically significant CMV infection or were classified as having a primary end point event by week 24 after ...
Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation Pharmacy Today, American Pharmacists Association, pharmacist.com

all 2 news articles » 


FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted - OncLive



OncLive
 
FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted 
OncLive
FDA approvals in chronic myeloid leukemia, cutaneous T-cell lymphoma, cytomegalovirus infection, and a tumor assay, and clinical holds lifted from CAR T-cell therapy trials. Welcome to OncLive News Network! I'm Gina Columbus. The FDA has approved ...

and more » 


Core-binding factor ? and Runx transcription factors promote adaptive natural killer cell responses - Science



Core-binding factor ? and Runx transcription factors promote adaptive natural killer cell responses 
Science
Although clonal expansion and immune memory are associated with adaptive immunity, Ly49H-expressing natural killer (NK) cells undergo clonal proliferation in response to mouse cytomegalovirus (MCMV) infection and form long-lived memory cells. Previous ...

 


NYSE, Nasdaq Open: Broadcom Climbs As This Biotech Stock Spikes - Investor's Business Daily



Investor's Business Daily
 
NYSE, Nasdaq Open: Broadcom Climbs As This Biotech Stock Spikes 
Investor's Business Daily
Late Wednesday, the drugmaker announced positive Phase 3 trial results from its Prevymis treatment for cytomegalovirus infection and disease in adult stem-cell transplant patients. McDonald's (MCD) and Coca-Cola (KO) took the Dow's hardest early hits ...

and more » 


Should CMV screening for babies be an option or mandate? - Wink News



Wink News
 
Should CMV screening for babies be an option or mandate? 
Wink News
The danger of this virus is that once infected, it stays in the body for life and there is no cure. The virus becomes apparent and can cause concern when an individual is pregnant or has a weakened immune system. A woman who obtains an active CMV ...

 


Expert Commentary: NYSDOH AIDS Institute Updated Guideline on Management of Immune Reconstitution ... - Medscape



Medscape
 
Expert Commentary: NYSDOH AIDS Institute Updated Guideline on Management of Immune Reconstitution ... 
Medscape
The Medical Care Criteria Committee of the New York State Department of Health AIDS Institute recently published an updated guideline on Management of immune reconstitution inflammatory syndrome (IRIS). The guideline addresses the following: timing of ...